MMJ Challenges DEA Rescheduling Process, Demanding Science Over Political Expediency
A federally compliant pharmaceutical developer is formally entering the DEA's cannabis rescheduling proceeding - not to oppose reclassification, but to demand that it be done right. MMJ International